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The CobraPLA
TM (CPLA) is a relatively new supraglottic
airway device that has not been sufficiently investigated.
Here, we performed a prospective observational study to
evaluate the efficacy of the CPLA during controlled ventila-
tion. In 50 anesthetized and paralyzed patients undergoing
elective surgery a CPLA was inserted and inflated to an
intracuff pressure of 60 cm H2O. The success rate of inser-
tion upon the first attempt was 82% (41/50), with a mean
insertion time of 16.3 ± 4.5 seconds. The adequacy of ven-
tilation was assessed by observing the end tidal CO2 wave-
form, movement of the chest wall, peak airway pressure (13.5
cm H2O), and leak fraction (4%). We documented the airway
sealing pressure (22.5 cm H2O) and noted that the the site
of gas leaks at that pressure were either at the neck (52%),
the abdomen (46%), or both (2%). In 44 (88%) patients, the
vocal cords were visible in the fiberoptic view through the
CPLA. There was no gastric insufflation during the anes-
thesia. Respiratory and hemodynamic parameters remained
stable during CPLA insertion. Postoperative blood staining of
CPLA was minimal, occurring in 22% (11/50) of patients.
Mild and moderate throat soreness was reported in 44%
(22/50) and 4% (2/50) of patients, respectively. Lastly, mild
dysphonia was observed in 6% (3/50) of patients and mild
dysphagia in 10% (5/50) of patients. Our results indicated
that the CPLA is both easy to place and allows adequate
ventilation during controlled ventilation.




Supraglottic airway devices have been intro-
duced in the clinical field as an alternative to tra-
ditional endotracheal intubation tubes. Recently, a
new supraglottic device, known as CobraPLA
TM
(CPLA, Engineered Medical systems, Indianapolis,
IN, USA) was introduced for clinical application.
The CPLA consists of a breathing tube with a
softened and widened distal end and an inflatable
cuff attached proximally to the wide end (Fig. 1).
The distal end of the CPLA is designed to sit in
the hypopharynx and seal the airway, thus al-
lowing positive pressure ventilation. When posi-
tioned in the hypopharynx, the CPLA also abuts
the structure of the laryngeal inlet. Oxygen and
inhalation anesthetics are delivered into the
trachea via a series of slotted openings at the
distal end of the ventilatory channel.
Alternatives to conventional intubation for air-
way management of difficult intubation,
1-3 posi-
tive pressure ventilation, or spontaneous ventila-
tion during general anesthesia for minor sur-
gery
4-8 have been explored. Such alternatives offer
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some advantages, in that they involve a relatively
simple insertion technique, resulting in less
hemodynamic changes.
1,9,10 However, the efficacy
of the CPLA has not been adequately investi-
gated. The purpose of this study, then, was to
evaluate whether the CPLA provides sufficient
ventilation and adequate oxygenation to patients
during controlled ventilation.
MATERIALS AND METHODS
We performed a prospective observational
study using the CPLA device during anesthesia
with controlled ventilation between December
2004 and March 2005. The study protocol was ap-
proved by the ethical committee of our institute.
After obtaining the patients' gender, age, height,
weight, and Mallampati classification, we ex-
plained general anesthesia and the CPLA, and
subsequently obtained written informed consent
from the patients. We studied 50 ASA I or II adult
patients with Mallampati I or II that were under-
going arthroscopic surgery of the knee (Table 1).
Exclusion criteria included any neck or upper
respiratory tract abnormalities, evidence of pul-
monary or cardiovascular disease, risk of aspira-
tion of gastric contents, and lateral decubitus or
prone position. Patients fasted overnight and were
intravenously premedicated with 0.004 mg/kg
glycopyrrolate and 2.0 - 3.0 mg midazolam. After
routine monitoring, general anesthesia was in-
duced intravenously with fentanyl (1 ug/kg), pro-
pofol (1.5 - 2.0 mg/kg) and rocuronium (0.5 mg/
kg). Anesthesia was maintained with sevoflurane
and 50% nitrous oxide in oxygen at a total gas
flow rate of 4 L/min.
We used a size 3 CPLA for patients whose
height was less than 180 cm, and a size 4 CPLA
for patients whose height was greater than 180
cm. For intubation, the patient's head was placed
on a pillow in a sniffing position, and a CPLA
lubricated with water-soluble jelly was inserted
along the hard palate until resistance was felt by
the investigator (investigators had performed
more than 20 prior CPLA insertions). We mea-
sured CPLA insertion time, defined as the time
between insertion of the tube into the patient's
mouth and the time of the first breath made by
manual ventilation. We recorded the number of
insertion and repositioning attempts if ventilation
was not appropriate according to auscultation,
movement of the chest wall, end-tidal CO2 curve,
gastric insufflation, and airway pressure. If the
CPLA was not placed by the second attempt, then
it was recorded as a failure, and the study was
terminated.
Upon successful insertion, the cuff was inflated
with air to a pressure of 60 cm H2O, using a ma-
nometer (Cuff Pressure Gauge, VBM Medizintechnik,
Sulz, Germany), and the initial air volume of the
cuff was recorded. The pilot balloon of the CPLA
was connected to a cuff pressure gauge through
a three-way stopcock, and cuff pressure was
recorded at 5 to 10 minute intervals until the cuff
pressure reached 100 cm H2O. Volume-controlled
ventilation of the lungs was applied, using a
volume-cycled anesthesia ventilator (Cato, Dra ¨ger,
Lu ¨beck, Germany). The tidal volume was 10 mL/
kg, and the respiratory rate was 12 breaths/min.
Blood pressure, heart rate, oxygen saturation, and
end-tidal CO2 tension were monitored with a
Solar 8000 monitor (GE Medical System Inc.,
Milwaukee, WI, USA). Airway pressure (peak,
plateau) and inspiratory and expiratory minute
volume data were collected at 5 minute intervals
following insertion of the CPLA. The sealing pres-
sure was recorded as the airway pressure at
which the aneroid manometer reached equilib-
rium after closing the expiratory valve of the
circle system at an O2 flow of 3 L/min. To prevent
lung barotraumas, we observed until the airway
pressure was 30 cm H2O. The direction of gas
leaks at the sealing pressure was measured by
auscultation with the stethoscope on the mouth,
stomach, and at both sites. After measuring the
Table 1. Patient Characteristics
Age (yrs) 33.2 ± 14.1
Sex (M/F) 28/22
Weight (kg) 66.1 ± 10.8
Height (cm) 168.4 ± 9.4
Mallampati class (I/II) 32/18
Tube size (3/4) 45/5
Data are the number of the patients or mean ± SD.Efficacy of the CobraPLA
TM
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leak pressure, the position of the CPLA was scored
by passing a fiberoptic bronchoscope through the
airway to the end of the device. Scoring was done
with the system proposed by Brimacombe
11 (1 =
vocal cords not fiberoptically visible; 2 = vocal
cords plus anterior epiglottis visible; 3 = vocal
cords plus posterior epiglottis visible; 4 = only
vocal cords visible). Gastric insufflation was moni-
tored by auscultation during the anesthesia. Com-
plications associated with CPLA insertion (blood
staining, dysphagia, dysphonia, and sore throat 1
day after operation) were also recorded.
Data were analyzed, using Statview (2nd edition,
SAS Institute Inc., Cary, NC, USA). Hemodynamic
and spirometry parameters were analyzed by a
repeated measure ANOVA. A p-value of less than
0.05 was considered statistically significant. Re-
sults are presented as mean ± SD or as actual
numbers.
RESULTS
We were able to insert the CPLA and initiate
ventilation in 41 (82%) and 9 (18%) patients upon
the first and second attempts, respectively. The
mean insertion time was 16.3 ± 4.5 seconds. At an
intracuff pressure of 60 cm H2O, the mean air
volume of the cuff was 56.3 ± 5.2 mL and 57.5 ±6.4
mL for size 3 and 4 CPLAs, respectively. Cuff
pressure was increasingly elevated from 62.4 cm
H2O at 2 min post-insertion, 70.6 cm H2O 30 min
post insertion later, and to 76.8 cm H2O 1 hour
post insertion (Fig. 2). The mean airway sealing
pressure was 22.5 ± 3.7 cm H2O, and at the sealing
pressure leaks were heard at the mouth in 26
patients, the stomach in 23 patients, and at both
sites simultaneously in 1 patient. The mean peak
airway pressure was maintained at 13.5 cm H2O.
Inspiratory minute ventilation was 7.2 ± 1.4 L/
min, and expiratory minute ventilation was 6.9 ±
0.7 L/min (Table 2). Airway position scores, as
determined by flexible fiberoptic bronchoscopy,
revealed a score 1 view in 6 patients, a score 2
view in 10 patients, a score 3 view in 18 patients,
and a score 4 view in 16 patients. Gastric insuf-
flation during the anesthesia was not observed
with the CPLA. Mean arterial pressure and heart
rate were maintained without significant change
during the procedure. Oxygen saturation and
end-tidal CO2 concentrations were also main-
tained without significant change (p > 0.05).
Upon removal of the CPLA, blood traces on the
device were visible in 11 (22%) cases. After 24
hours, mild/moderate sore throat was present in
22/2 (44%/4%) cases, mild dysphonia was re-
ported in 3 (6%) cases, and mild dysphagia was
noted in 5 (10%) cases.
DISCUSSION
We have demonstrated that the CPLA device
provided a patent airway during controlled ven-
tilation of the lungs and that the softened distal
tip of the CPLA head provided easy passage of
the device into the hypopharynx. The size of
CPLA used for this study differed from the
manufacturer's recommendation of a size 3 or 4
tube for adult weights > 35 kg and 70 kg, respec-
Fig. 2. Changes in intracuff pressure throughout the
experiment with CobraPLA
TM. Data are given as mean ±
SD.
Table 2. Respiratory Data
Airway sealing pressure (cm H2O) 22.5 ± 3.7
Inspiratory MV (L/min) 7.2 ± 1.4
Expiratory MV (L/min) 6.9 ± 0.7
Peak airway pressure (cm H2O) 13.5 ± 2.7
Plateau airway pressure (cm H2O) 11.7 ± 6.8
MV, minute ventilation.
All values are expressed as mean ± SD.Sang Beom Nam, et al.
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tively. However, Agro et al.
12 used a size 3 CPLA
for patients whose weight was less than 60 kg,
size 4 for those weighing 60 - 80 kg, and size 5 for
those whose weight was more than 80 kg. In a
preliminary study, a size 4 CPLA had a greater
resistance than size 3 tubes when inserted into the
mouth , and, thus, we used size 3 CPLAs for most
of the patients. Nonetheless, we feel that a more
extensive evaluation of proper CPLA size is neces-
sary.
In order to determine the efficacy of the CPLA
device, measurement of the rate of successful
insertion was essential. In our study, the success
rates for first and second insertion attempts were
82% and 18%, respectively. The mean insertion
time of the CPLA was 16.3 seconds, which was





the cuff of the CPLA to 60 cm H2O, the initial
volume was 56.3 ± 5.2 mL and 57.5 ± 6.4 mL for
size 3 and 4 CPLAs, respectively. These volumes
were compatible with the manufacturer's recom-
mended volume limits of 65 or 70 mL for the size
3 or 4 CPLAs, respectively. The cuff pressure of
the CPLA increased progressively throughout the
procedure to approximately 80 cm H2O because
we used N2O gas, which has a greater diffusion
capacity for inflation than air.
16,17 A higher concen-
tration of N2O results in higher intracuff pres-
sure.
16
Pharyngeal mucosal perfusion is reduced pro-
gressively in the posterior pharynx when the
mucosal pressure is increased from 34 to 80 cm
H2O with a cuffed oropharyngeal airway,
18 and
the incidence of postanesthetic tracheal mucosal
injuries can be minimized by preventing excessive
cuff pressure.
19 Although we did not examine the
correlation between intracuff pressure of the
CPLA and pharyngeal mucosal injury, it is clear
that a lower pressure of the device may also
prevent mucosal ischemia. Thus, we believe that
the cuff pressure of the CPLA should be moni-
tored and maintained at initial values in order to
prevent excessive pressure on the pharyngeal
mucosa.
Using volume-controlled mechanical ventila-
tion, the mean peak airway pressure was 13 cm
H2O when we set the tidal volume at 10 mL/kg.
This value was less than those obtained with a
tidal volume of 12 mL/kg for LTs
20 and for
LMAs.
21 The leak pressure was 22.5 cm H2O,
which was higher than the airway pressure, and,
thus, made appropriate ventilation of the lungs
with the CPLA possible. The mean leak pressure
in our study closely matched the findings of a
previous study of CPLAs by Akca et al,
8 who
suggested that, in comparing CPLAs with LMAs,
that the CPLA is a safer airway management
device because it has both a higher leak pressure
and a smaller air volume suctioned via the
nasogastric tube than LMAs.
We also observed the location of gas leaks.
Leakage to the mouth was observed in 26 cases
(52%), leakage to the stomach was present in 23
cases (46%), and leakage to both sites was present
in 1 case. Gas leaks to the stomach are more
problematic than leaks to the mouth, as they can
cause inflation of the stomach and intestines, as
well as an increased risk of gastric content aspira-
tion. The possibility of gastric content aspiration
increased when airway pressure is higher than
leak pressure. We believe that the possibility of
gastric insufflation with the CPLA device may be
low during positive pressure ventilation in
patients who do not require high inflation pres-
sure to produce a normal tidal volume. The
expired tidal volume was approximately 4% less
than the inspired volume; however, according to
auscultation with a stethoscope placed on the
neck and stomach region, no significant air leaks
were detected at the mean peak respiratory
pressure of 13 cm H2O with an intra-balloon
pressure of 60 cm H2O. In the present study, the
highest peak airway pressure was 19 cm H2O, and
the highest leak pressure was 27 cm H2O. This
leak fraction was lower than other supraglottic
airway devices, which are from 13% at 15 cm H2O
to 27% at 30 cm H2O ventilation pressure for
LMAs,
4 or 10% for LTs.
20 We suggest that a CPLA
cuff pressure of 60 cm H2O should be sufficient to
ensure positive pressure ventilation with a tidal
volume of 10 mL/kg.
Proper anatomic positioning of airway devices
is necessary for optimal functioning. The mean
fiberoptic position score was 2.94, and perfect
positioning (score 4) was found in only 32% of
patients overall. Fiberoptic assessment of the
CPLA indicated that, while alignment of theEfficacy of the CobraPLA
TM
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slotted ventilation opening of the CPLA with the
laryngeal aperture may not be anatomically per-
fect, its function was clinically satisfactory in the
majority of patients. Our data show that sufficient
ventilation and oxygenation could be achieved
using the CPLA. Further, hemodynamic parame-
ters before and after induction of general anes-
thesia were not significantly changed with the
CPLA, suggesting that the CPLA has little effect
on the cardiovascular system, compared to con-
ventional endotracheal intubations.
Minimal blood staining of the CPLA was found
in 11 patients; however, they did not require treat-
ment and had no further bleeding in the post-an-
esthetic care room. The incidence of postoperative
mild and moderate sore throats in this study was
44% and 4%, respectively. Akca et al.,
8 using a
100-mm visual analog scale score, reported that
the incidence of a sore throat of more than 10 mm
is 40%. Mild dysphonia and dysphagia was ex-
perienced by 3 and 5 of the patients, respectively;
however, symptoms subsided one day after the
operation.
This was an observational study and was
limited by including only experimental patients
who were undergoing arthroscopic knee surgery
and not including a comparison with the other
supraglottic airway devices. In conclusion, the
CPLA appears to be a simple, easy to insert, and
safe airway management device that allows effec-
tive ventilation during anesthesia with controlled
ventilation.
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